Summary
The pharmacokinetics of ketorolac tromethamine, a potent non-narcotic analgesic agent used for relief of moderate to severe pain, has been studied in 15 healthy volunteers who received single 10 mg doses intravenously (i.v.), intramuscularly (i.m.) and orally (p.o.) in a three-way cross-over design.
The kinetics of i.v. ketorolac were characterized by a terminal half-life of 5.09 h, a small plasma clearance (CL = 0.35 ml·min−1·kg−1) and a small tissue distribution (Vss=0.111·kg−1, Vβ=0.17 l·kg−1; mean (SD). Following i.m. and p.o. administration, peak levels of approximately 0.8 µg/ml were rapidly attained (tmax = 0.8 and 0.9 h, respectively) and the systemic bioavailability was essentially complete.
This is a preview of subscription content, log in via an institution to check access.
References
Muchowski JM, Unger SH, Ackrell J, Cheung P, Cooper GF, Cook J, Gallegra P, Halpern O, Koehler R, Kluge AF, Van-Hurn AR, Antonio Y, Carpiu H, Franco F, Galeazzi E, Garcia I, Greenhous R, Guzman A, Iriate J, Leon A, Pena A, Perez V, Valdez D, Ackerman N, Ballaron SA, Murthy DVK, Rovito JR, Tomolonis AJ, Young JM, Rooks WH (1982) Synthesis and anti-inflammatory and analgesic activity of 5-aroyl-1,2-dihydro-3H-pyrrole [1,2-a] pyrrole-1-carboxylic-acids and related compounds. J Med Chem 28: 1037–1049
Rooks WH, Tomolonis AJ, Maloney PJ, Wallach MB, Schuler ME (1982) The analgesic and anti-inflammatory profile of (±)-5-benzoyl-1,2-dihydro-3H-pyrrole [1,2-a] pyrrole-1-carboxylic acid (RS-37619). Agents Actions 12: 684–690
Rooks WH, Maloney PJ, Shott LD, Schuler ME, Sevelius H, Strosberg AH, Tannenbaum L, Tomolonis AJ, Wallach MB, Waterburg D, Yee JP (1985) The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt. Drug Exp Clin Res 11: 479–482
Bloomfield SS, Mitchell J, Cissell G, Barden TP (1984) RS-37619 and aspirin analgesia for post-partum uterine cramps. Clin Pharmacol Ther 35: 228 (abstract)
Yee J, Brown CR, Sevelius H, Wild V (1984) The analgesic efficacy of (±)-5-benzoyl-1-2,dihdro-3H pyrrole [1,2-a] pyrrole-1-carboxylic acid, tromethamine salt in postoperative pain. Clin Pharmacol Ther 35: 284 (abstract)
Yee J, Allison C, Koshiver J, Brown CR (1986) Analgesia from intramuscular ketorolac tromethamine compared to morphine sulfate in severe pain following major surgery. Pharmacotherapy 6: 253–261
Wu AT, Huang BL, Massey IJ, Kushinsky S (1986) Quantification of ketorolac in plasma and aqueous humor by high performance liquid chromatography. Am Pharm Assoc Abstracts 16: 145
Brown PR, Manno JE (1978) ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 67: 1687–1691
Metzler CM, Weiner DL (1986) PCNONLIN User's guide. Statistical Consultants, Inc, Lexington, KY, USA
Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd edn. Marcel Dekker, New York
Mroszczak EJ, Lee FW, Combs D, Sarnquist FH, Huang BL, Wu AT, Tokes LG, Maddox ML, Cho DK (1987) Ketorolac tromethamine absorption, distribution, metabolism, excretion and pharmaokinetics in animals and man. Drug Metab Dispos 15: 618–626
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jung, D., Mroszczak, E. & Bynum, L. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration. Eur J Clin Pharmacol 35, 423–425 (1988). https://doi.org/10.1007/BF00561376
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561376